Desq Long
Sign in

Company

Oric Pharmaceuticals, Inc.

ORIC · CIK 0001796280

SEC FORM 4
$5,600.00

Oric Pharmaceuticals, Inc. (ORIC)

Acquisition (code M) of 3,500 shares at $1.60 per share.

Reporting Person Heyman Richard A. · Transaction Code M

Traded Oct 1, 2026 · Disclosed Oct 2, 2026

Source: SEC Form 4 · 0001584759-26-000017 · filed 2026-10-02 · View filing →

SEC FORM 4
$45,199.35

Oric Pharmaceuticals, Inc. (ORIC)

Sale of 3,500 shares at $12.9141 per share.

Reporting Person Heyman Richard A. · Transaction Code S

Traded Oct 1, 2026 · Disclosed Oct 2, 2026

Source: SEC Form 4 · 0001584759-26-000017 · filed 2026-10-02 · View filing →

SEC FORM 4
$41,325.12

Oric Pharmaceuticals, Inc. (ORIC)

Sale of 3,200 shares at $12.9141 per share.

Reporting Person Heyman Richard A. · Transaction Code S

Traded Oct 1, 2026 · Disclosed Oct 2, 2026

Source: SEC Form 4 · 0001584759-26-000017 · filed 2026-10-02 · View filing →

SEC FORM 4
$58,424.00

Oric Pharmaceuticals, Inc. (ORIC)

Acquisition (code M) of 13,400 shares at $4.36 per share.

Reporting Person Piscitelli Dominic · Officer Title Chief Financial Officer · Transaction Code M

Traded Sep 28, 2026 · Disclosed Sep 29, 2026

Source: SEC Form 4 · 0001695028-26-000010 · filed 2026-09-29 · View filing →

SEC FORM 4
$181,257.78

Oric Pharmaceuticals, Inc. (ORIC)

Sale of 13,400 shares at $13.5267 per share.

Reporting Person Piscitelli Dominic · Officer Title Chief Financial Officer · Transaction Code S

Traded Sep 28, 2026 · Disclosed Sep 29, 2026

Source: SEC Form 4 · 0001695028-26-000010 · filed 2026-09-29 · View filing →

SEC FORM 4
$2,616.00

Oric Pharmaceuticals, Inc. (ORIC)

Acquisition (code M) of 600 shares at $4.36 per share.

Reporting Person Piscitelli Dominic · Officer Title Chief Financial Officer · Transaction Code M

Traded Sep 24, 2026 · Disclosed Sep 25, 2026

Source: SEC Form 4 · 0001695028-26-000008 · filed 2026-09-25 · View filing →

SEC FORM 4
$1,350.00

Oric Pharmaceuticals, Inc. (ORIC)

Sale of 100 shares at $13.50 per share.

Reporting Person Piscitelli Dominic · Officer Title Chief Financial Officer · Transaction Code S

Traded Sep 24, 2026 · Disclosed Sep 25, 2026

Source: SEC Form 4 · 0001695028-26-000008 · filed 2026-09-25 · View filing →

SEC FORM 4
$6,752.50

Oric Pharmaceuticals, Inc. (ORIC)

Sale of 500 shares at $13.505 per share.

Reporting Person Piscitelli Dominic · Officer Title Chief Financial Officer · Transaction Code S

Traded Sep 24, 2026 · Disclosed Sep 25, 2026

Source: SEC Form 4 · 0001695028-26-000008 · filed 2026-09-25 · View filing →

SEC FORM 4
$226,720.00

Oric Pharmaceuticals, Inc. (ORIC)

Acquisition (code M) of 52,000 shares at $4.36 per share.

Reporting Person Piscitelli Dominic · Officer Title Chief Financial Officer · Transaction Code M

Traded Aug 26, 2026 · Disclosed Aug 28, 2026

Source: SEC Form 4 · 0001695028-26-000006 · filed 2026-08-28 · View filing →

SEC FORM 4
$150,000.00

Oric Pharmaceuticals, Inc. (ORIC)

Acquisition (code M) of 25,000 shares at $6 per share.

Reporting Person Piscitelli Dominic · Officer Title Chief Financial Officer · Transaction Code M

Traded Aug 26, 2026 · Disclosed Aug 28, 2026

Source: SEC Form 4 · 0001695028-26-000006 · filed 2026-08-28 · View filing →

SEC FORM 4
$1,053,814.30

Oric Pharmaceuticals, Inc. (ORIC)

Sale of 77,000 shares at $13.6859 per share.

Reporting Person Piscitelli Dominic · Officer Title Chief Financial Officer · Transaction Code S

Traded Aug 26, 2026 · Disclosed Aug 28, 2026

Source: SEC Form 4 · 0001695028-26-000006 · filed 2026-08-28 · View filing →